Literature DB >> 24497857

Role of clinical and paraclinical manifestations of methanol poisoning in outcome prediction.

Shahin Shadnia1, Mojgan Rahimi1, Kambiz Soltaninejad2, Amir Nilli3.   

Abstract

BACKGROUND: Methanol poisoning is one of the most important poisoning due to drinking of illegal and non-standard alcoholic beverage in some countries. Relatively limited studies have been carried out to identify the prognostic factors in methanol poisoning.
MATERIALS AND METHODS: We performed a retrospective study on acute methanol-intoxicated patients, which were admitted on the Loghman Hakim Hospital Poison Center (Tehran, Iran) over a 24-month period. The demographic data, clinical manifestations and paraclinical findings, therapeutic interventions and outcome (survivors with or without complications and non-survivors) were extracted.
RESULTS: We evaluated 30 patients with methanol poisoning during 2 years. All of the patients were male; with the median age of 25.5 years. Visual disturbances, respiratory manifestations, and loss of consciousness were the most common clinical manifestations on admission time. The results of paraclinical manifestations on admission time were as following: The median of blood methanol level was 20 mg/dL. The median of pH, PaCO2 and HCO3 was 7.15, 22.35 mmHg and 7.2 mEq/L, respectively. Hyperglycemia was observed in 70% of the patients and the median of blood glucose was 184.5 mg/dL. In fourteen of the patients hemodialysis was performed. Median duration of hospitalization was 48 h. Nine of the patients died. There was a significant difference between survivors and non-survivors with regard to coma, blood methanol level, and PaCO2 and blood glucose. Furthermore, we did not observe a significant difference between these two groups regarding to pH, HCO3 level, and time interval between alcohol ingestion to hospital admission and beginning of hemodialysis.
CONCLUSION: Regarding the results of this study, it can be suggested that coma, PaCO2 and hyperglycemia on admission time could be used as strong predictors of poor outcome.

Entities:  

Keywords:  Hyperglycemia; methanol; outcome; partial pressure of carbon dioxide; poisoning; prognostic factors

Year:  2013        PMID: 24497857      PMCID: PMC3897070     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


INTRODUCTION

Methanol is a toxic alcohol, which is widely used as a solvent and to denature ethanol.[1] Almost all cases of acute methanol toxicity result from ingestion. Rarely, poisoning follows inhalation or dermal absorption. Ingestion of as little as 30 mL of pure methanol has caused permanent blindness and 30-240 mL is potentially fatal, though individual susceptibility varies widely.[2] Methanol itself has a relatively low toxicity, but produces toxic metabolites as formaldehyde and formic acid. There is a direct correlation between formic acid concentration and morbidity and mortality.[3] The acidosis appears to be caused by formic acid production and formic acid/formate is the principal cause of ocular toxicity.[2] As methanol is cheap and easily accessible, it has been used in the production of imitated spirits and wine, so cause the mortality and or morbidity in many people.[4] In Iran, according to legal and religious ban in production of alcoholic beverages, the use of illegal and non-standard alcoholic beverages is common and it may be a major role for an increase in the prevalence of methanol-intoxication among the alcohol abusers in the country.[56] There are relatively limited studies that reported the parameters such as respiratory arrest, coma, serum formate concentration, severe metabolic acidosis, blood methanol level as a criterion for the diagnosis and prognosis of acute methanol poisoning.[678] The aim of this study was to assess the clinical manifestations and paraclinical findings in methanol intoxication and their role in the prediction of outcome.

METHODS

This was a retrospective study on acute methanol-intoxicated patients, which were admitted on the Loghman Hakim Hospital Poison Center (LHHPC) over a 24-month period. The diagnosis in all cases was based on the history of exposure, clinical manifestations and positive blood methanol level. Acute methanol-intoxicated patients with no history of diabetes, cardiovascular, respiratory, renal and hepatic failure, and no advanced medical management such as hemodialysis and antidote therapy for methanol poisoning in any medical center before admission in LHHPC, were included in the study. Furthermore, we exclude the cases with co-ingestion of other drugs and chemicals except ethanol based on the history and/or toxicological data. The qualifying case records were extracted from the patients, medical files. We collected and abstracted patients, information regarding gender, age, history of chronic abuse of alcohol, type of alcoholic beverage, time between intake of alcohol to admission on hospital, signs and symptoms of intoxication on admission time, laboratory findings, therapeutic interventions, duration of hospitalization and outcome. Data were kept confidential in all stages of the study. Coma grade was calculated on admission time in the emergency department.[9] All patients were followed until discharge from the hospital or death. According to the outcome, the patients were divided into survivors (with or without complications) and non-survivors. All data were analyzed with SPSS software (version 12) and STATA software (version 11). The data were expressed as median or mean ± SD for numeric variables and as frequency and percentage for categorical variables. Chi-square test was used for statistical comparison of qualitative variables. The fisher exact test was used if the number of cases was less than 5. The normal distribution of quantitative variables was tested by Kolmogorov-Smirnov test. The statistical comparison was carried out with Mann-Whitney U-test for non-parametric variables and independent student t-test was used for parametric variables. We used the Pearson test for the analysis of correlation in the continuous variables and odds ratios was calculated for the binary variables. P values of 0.05 or less were considered to be statistically significant.

RESULTS

A total of 30 patients with acute methanol poisoning were included in the study. All of the patients were male; with the median age of 25.5 years (range 15-52 years) [Table 1].
Table 1

Comparison of demographic, clinical and para-clinical manifestations in survival and non-survival groups

Comparison of demographic, clinical and para-clinical manifestations in survival and non-survival groups In all of the patients, the route of exposure was oral ingestion. Only 9 (30%) of the patients had the history of chronic misuse of alcohol. In 24 (80%) of the patients, the type of alcohol was illegal hand-made alcoholic beverages. Only 3 (10%) of the patients had a history of consumption of industrial alcohol (a kind of alcoholic product that used only as a household cleaner and not for a drink), and in 3 (10%) of the patients the type of alcohol source was unknown. The median time between intake of alcohol to admission on a hospital was 24 h (range 4-96 h) [Table 1]. Visual disturbances, respiratory manifestations, and loss of consciousness were the most common clinical manifestations 64% (95% confidence interval [CI]: 0.44-0.80), 47% (95% CI: 0.28-0.66) and 47% (95% CI: 0.28-0.66) respectively on admission time. 13 patients (43%) had mydriasis. In 5 (17%) of the patients, the pupils were unresponsive to light [Table 2].
Table 2

Distribution of patients according to clinical manifestations on admission time

Distribution of patients according to clinical manifestations on admission time The median of blood methanol level was 20 mg/dL (range 7-75 mg/dL) [Table 1]. A total of 11 patients (37%) had methanol level 20≤ mg/dL to <50 mg/dL and seven patients (23%) had methanol level more than 50 mg/dL, one of them survived and the other six ones died. Only three patients (10%) had methanol level 5≤ mg/dL to <10 mg/dL and in others, methanol level was 10≤ mg/dL to <20 mg/dL. Analyze of venous blood gas on admission showed that the median of pH was 7.15 with a range of 6.73-7.32 [Table 1]. Most of the patients (60%) had pH 7< to ≤7.20, 12 of them survived and six others died. Furthermore from seven patients who had pH 7.20< to ≤7.30, six patients survived and only one patient died. All of the three patients who had the pH above 7.30, survived and two patients who had the pH less than 7 died. The median of PaCO2 was 22.35 mmHg (range of 2.70-46.60 mmHg) [Table 1]. In most of the patients (80%), PaCO2 was less than 35 mmHg. Only two patients (7%) had PaCO2 35≤ mmHg to <45 mmHg, one of them survived and the other died [Figure 1]. Figure 2 shows the relationship between pH and PaCO2 in survivors and non-survivors.
Figure 1

Distribution of patients regarding to their PaCO2 and outcome

Figure 2

Relationship of pH with PaCO2 in survivors and non-survivors

Distribution of patients regarding to their PaCO2 and outcome Relationship of pH with PaCO2 in survivors and non-survivors The median of HCO3 was 7.2 mEq/L with a range of 1-20 mEq/L [Table 1]. In most of the patients (47%), HCO3 level was 5< mEq/L to ≤10 mEq/L. None of them had HCO3 level more than 20 mEq/L, and only five patients (17%) had HCO3 level 15< mEq/L to ≤20 mEq/L, three of them survived and two others died. Most of the patients (60%) had leukocytosis, and in others the numbers of white blood cells (WBC) were within normal range. The median number of WBC was 13400/μL with the range of 6000-26400/μL. 40% of the patients showed hyperkalemia and in others the level of potassium was in the normal range. Hyperglycemia was also observed in 21 (70%) of the patients and in others, the blood glucose level was in the normal range. The median of blood sugar was 184.5 mg/dL with the range of 70-540 mg/dL [Table 1]. All patients were given sodium bicarbonate and folic acid. The median of total dose of sodium bicarbonate, which was administered in patients, was 425 mEq/L with a range of 75-2100 mEq/L. Except for two patients; all of them were treated with oral ethanol solution 10% as an antidote. The median duration of ethanol therapy was 1 day with the range of 0-4 days. In 14 (46%) of the patients hemodialysis was performed. 4 from 16 patients who received no hemodialysis died. The median time interval between hospital admission and beginning of hemodialysis was 4 h with the range of 0-17 h [Table 1]. A total of 8 (27%) of the patients were admitted in intensive care unit. The median duration of hospitalization was 48 h (range 3-240 h) [Table 1]. Total 9 (30%) of the patients died; while two of the remaining survivors became blind. Mortality rate in comatose and non-comatose cases was 50% versus 12.5%, respectively with odds ratio 7 (1.14-42.97, 95% CI). The mortality rate in patients with respiratory depression was 80% in compare to 20% in patients without depression of respiration, with odds ratio 16 (1.45-176.45, 95% CI). There was a correlation between methanol level (r = 0.44, P = 0.01), PaCO2 (r = 0.43, P = 0.02), leukocytosis (r = 0.41, P = 0.03), blood sugar (r = 0.60, P = 0.000) and death.

DISCUSSION

The present study shows that the oral ingestion of illegal hand-made spirits is a most common cause of acute methanol poisoning in Tehran. This result is similar to our previous finding and other researchers.[6710] In Iran, according to national regulations, selling, buying, and consumption of alcoholic drinks is a punishable crime. Therefore, the use of homemade, illegal and non-standard alcoholic beverages can cause acute methanol intoxication. The present results show that the young men are the major patients suffer from methanol poisoning. This is in concordance with our previous studies about general pattern of acute chemical and pharmaceutical poisoning in Tehran.[5] In this study, the median time interval between methanol intakes to admission on a hospital was 24 h. It can be due to this fact that methanol is not toxic by itself and it must be metabolized to toxic metabolites like as formate. Methanol is oxidized by alcohol dehydrogenase to formaldehyde, which is oxidized to formic acid by formaldehyde dehydrogenase. Then, formic acid is converted to carbon dioxide and water. This process is time consuming and from this view, the clinical presentations in methanol poisoning appear after a latent period.[11] The mortality in our study was 30%. It is similar to our previous finding about mortality in acute methanol poisoning and other researchers.[6712] The ophthalmic, respiratory, and central nervous system involvements were the most common clinical manifestations. These results supported by previous studies.[6813] Although, in the present study, the mean blood methanol level in our patients is lower than other studies,[8] but it is similar to our previous result.[6] This may be related to the delay of admission of the patients in the hospital.[6] The treatment, including duration of ethanol therapy, total dose of bicarbonate and time interval between hospital admission and beginning of hemodialysis was similar in both survivor and non-survivor groups; so the difference in the outcome of the patients could be related to their clinical and paraclinical status on admission time. In the present study, we found a significant difference between survivors and non-survivors with regard to coma grade, depression of respiration, PaCO2, blood methanol level, leukocytosis, and blood sugar. Furthermore, there was a correlation between coma grade, depression of respiration, PaCO2, blood methanol level, leukocytosis, blood sugar and death, which is the same as previous published data.[6781112] Respiratory arrest and increased PaCO2 in the severely acidotic methanol-intoxicated cases have been suggested as a new marker.[78] The current study confirms earlier studies showing mortality correlating with the lack of compensatory hyperventilation in spite of and only when there is a profound metabolic acidosis. Hyperglycemia is recently shown as a prognostic marker[12] and the same finding in this study is thus very interesting. The exact mechanism of hyperglycemia is not clear but it has been supposed that methanol poisoning can be associated with acute pancreatitis and this can be suggestive in creating hyperglycemia.[14] Furthermore increased counter regulatory hormones from the acute stress of methanol poisoning could be another suggestive mechanism.[15] In spite of the results of previous studies, which showed a correlation between blood pH and poor prognosis,[67811] we did not find any significant difference in blood pH between survivor and non-survivor groups. One of the explanations is that the blood H + concentration is regulated by PCO2 and level of blood HCO3, so it will not necessarily be found in all patient populations depending on the their compensatory situations. The other reasons could be the fact that this study is retrospective and the number of patients is relatively small, which could be considered as a limitation of this study.

CONCLUSION

According to the results of this study, it could be concluded that coma, respiratory depression, PaCO2 and hyperglycemia are strong predictors of poor outcome. Furthermore, hyperglycemia might be a new prognostic factor in methanol poisoning, but further studies are needed to determine whether controlling hyperglycemia has therapeutic consequences.
  13 in total

1.  Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs.

Authors:  K E Hovda; O H Hunderi; A-B Tafjord; O Dunlop; N Rudberg; D Jacobsen
Journal:  J Intern Med       Date:  2005-08       Impact factor: 8.989

2.  Short-acting barbiturate overdosage. Correlation of intoxication score with serum barbiturate concentration.

Authors:  M M McCarron; B W Schulze; C B Walberg; G A Thompson; A Ansari
Journal:  JAMA       Date:  1982-07-02       Impact factor: 56.272

3.  Outcomes of visual disturbances after methanol poisoning.

Authors:  Hossein Sanaei-Zadeh; Nasim Zamani; Shahin Shadnia
Journal:  Clin Toxicol (Phila)       Date:  2011-02       Impact factor: 4.467

4.  Pancreatic injury following acute methanol poisoning.

Authors:  P Hantson; P Mahieu
Journal:  J Toxicol Clin Toxicol       Date:  2000

5.  Pattern of acute poisoning in Tehran-Iran in 2003.

Authors:  Shahin Shadnia; Hadi Esmaily; Ghazal Sasanian; Abdolkarim Pajoumand; Hosein Hassanian-Moghaddam; Mohammad Abdollahi
Journal:  Hum Exp Toxicol       Date:  2007-09       Impact factor: 2.903

6.  Prognostic factors in methanol poisoning.

Authors:  H Hassanian-Moghaddam; A Pajoumand; S M Dadgar; Sh Shadnia
Journal:  Hum Exp Toxicol       Date:  2007-07       Impact factor: 2.903

7.  Prognostic factors in patients with methanol poisoning.

Authors:  J J Liu; M R Daya; O Carrasquillo; S N Kales
Journal:  J Toxicol Clin Toxicol       Date:  1998

8.  Methanol mass poisoning in Estonia: outbreak in 154 patients.

Authors:  R Paasma; K E Hovda; A Tikkerberi; D Jacobsen
Journal:  Clin Toxicol (Phila)       Date:  2007       Impact factor: 4.467

Review 9.  American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning.

Authors:  Donald G Barceloux; G Randall Bond; Edward P Krenzelok; Hannah Cooper; J Allister Vale
Journal:  J Toxicol Clin Toxicol       Date:  2002

10.  Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak.

Authors:  Raido Paasma; Knut Erik Hovda; Dag Jacobsen
Journal:  BMC Clin Pharmacol       Date:  2009-03-27
View more
  8 in total

1.  Prognostic Factors of Outcome in Methanol Poisoning; an 8-year Retrospective Cross-sectional Study.

Authors:  Vahid Yousefinejad; Badia Moradi; Anvar Mohammadi Baneh; Farshad Sheikhesmaeili; Asrin Babahajian
Journal:  Arch Acad Emerg Med       Date:  2020-09-05

2.  A cross-sectional multicenter linkage study of hospital admissions and mortality due to methanol poisoning in Iranian adults during the COVID-19 pandemic.

Authors:  Nasim Zamani; Rebecca McDonald; Seyed Amirhosein Mahdavi; Maryam Akhgari; Ali-Asghar Kolahi; Farzad Gheshlaghi; Ali Ostadi; Ahmad Dehghan; Mohammad Moshiri; Morteza Rahbar-Taramsari; Mohammad Delirrad; Neda Mohtasham; Saeed Afzali; Sara Ebrahimi; Pardis Ziaeefar; Navid Khosravi; Amir Mohammad Kazemifar; Mohammadreza Ghadirzadeh; Hoorvash Farajidana; Tahereh Barghemadi; Farangis Sadeghi; Seyed Kaveh Hadeiy; Mehdi Hadipourzadeh; Javad Mesbahi; Mohammad-Reza Malekpour; Mohsen Arabi; Farkhondeh Jamshidi; Bita Dadpour; Knut Erik Hovda; Hossein Hassanian-Moghaddam
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

3.  Diabetic ketoacidosis as a complication of methanol poisoning; a case report.

Authors:  Azam Erfanifar; Mahsa Mahjani; Sara Salimpour; Nasim Zamani; Hossein Hassanian-Moghaddam
Journal:  BMC Endocr Disord       Date:  2022-06-02       Impact factor: 3.263

4.  Epidemiology of Alcohol Poisoning and Its Outcome in the North-West of Iran.

Authors:  Hamid Reza Morteza Bagi; Mohammad Tagizadieh; Payman Moharamzadeh; Mahboob Pouraghaei; Aynaz Kahvareh Barhagi; Kavous Shahsavari Nia
Journal:  Emerg (Tehran)       Date:  2015

5.  Methyl alcohol poisoning causing putamen necrosis.

Authors:  Seyed Mostafa Mirakbari
Journal:  Indian J Crit Care Med       Date:  2015-03

6.  Development and validation of a risk-prediction nomogram for in-hospital mortality in adults poisoned with drugs and nonpharmaceutical agents: An observational study.

Authors:  Catalina Lionte; Victorita Sorodoc; Elisabeta Jaba; Alina Botezat
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 7.  Methanol poisoning as a new world challenge: A review.

Authors:  Zahra Nekoukar; Zakaria Zakariaei; Fatemeh Taghizadeh; Fatemeh Musavi; Elham Sadat Banimostafavi; Ali Sharifpour; Nasrin Ebrahim Ghuchi; Mahdi Fakhar; Rabeeh Tabaripour; Sepideh Safanavaei
Journal:  Ann Med Surg (Lond)       Date:  2021-06-02

8.  Prediction and validation of hemodialysis duration in acute methanol poisoning.

Authors:  Philippe Lachance; Fabrice Mac-Way; Simon Desmeules; Sacha A De Serres; Anne-Sophie Julien; Pierre Douville; Marc Ghannoum; Mohsen Agharazii
Journal:  Kidney Int       Date:  2015-08-05       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.